Two Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis
1 other identifier
interventional
85
1 country
1
Brief Summary
The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allowing up to 3 surgical lavages and allocating patients into a two-week's and a four week's randomization arm
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 18, 2018
CompletedFirst Posted
Study publicly available on registry
August 6, 2018
CompletedAugust 6, 2018
July 1, 2018
2.8 years
January 16, 2017
July 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical Remission of systemic infection
Measurement of fever.
6 months
Sequels
Patient's remaining gait disorders. * range of movement in adjacent joints of former infection * questionnaire regarding persistant pain and handicaps (open wording)
6 months
Secondary Outcomes (3)
Wound redness
6 months
Wound discharge
6 months
Presence of pus
6 months
Study Arms (4)
Two week's arm - surgery
EXPERIMENTALThe investigators perform a surgical drainage and removal of the infected orthopedic implant.
Four week's arm - surgery
ACTIVE COMPARATORThe investigators surgically remove the infected implant.
Two week's arm - drugs
EXPERIMENTALThe investigators perform a surgical drainage and removal of the infected orthopedic implant. They start an empirical antibiotic treatment based on patient's history and co-morbidities, such as vancomycin or amoxicillin/clavulanic acid. The adapt later on the targeted antibiotic therapy according to the causative pathogens and their antibiotic susceptibility testing.
Four week's arm - drugs
ACTIVE COMPARATORThe investigators surgically remove the infected implant and all soft tissue infection. Instead of a total of 2 week's of antibiotic therapy, they administer a total of 4 weeks of systemic antibiotic therapy targeted to the pathogen(s).
Interventions
The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.
The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.
After the surgical implant removal, the investigators prescribe a total of 2 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.
After the surgical implant removal, the investigators prescribe a total of 4 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.
Eligibility Criteria
You may qualify if:
- Age \>17 years
- Microbiologically-confirmed septic arthritis
- At least one surgical drainage/lavage
You may not qualify if:
- Presence of osteosynthesis material in the vicinity of the articulation
- Presence of a concomitant infection needing more than 2 week's of antibiotic therapy
- More than 3 surgical drainages
- Life expectancy less than 6 months
- Chronic osteomyelitis in vicinity of the arthritis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Geneva University Hospitals
Geneva, 1211, Switzerland
Related Publications (2)
Uckay I, Tovmirzaeva L, Garbino J, Rohner P, Tahintzi P, Suva D, Assal M, Hoffmeyer P, Bernard L, Lew D. Short parenteral antibiotic treatment for adult septic arthritis after successful drainage. Int J Infect Dis. 2013 Mar;17(3):e199-205. doi: 10.1016/j.ijid.2011.12.019. Epub 2012 Nov 22.
PMID: 23183231BACKGROUNDGjika E, Beaulieu JY, Vakalopoulos K, Gauthier M, Bouvet C, Gonzalez A, Morello V, Steiger C, Hirsiger S, Lipsky BA, Uckay I. Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial. Ann Rheum Dis. 2019 Aug;78(8):1114-1121. doi: 10.1136/annrheumdis-2019-215116. Epub 2019 Apr 16.
PMID: 30992295DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ilker Uçkay, MD
University Hospital, Geneva
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending, Docent Dr. med Ilker Uçkay
Study Record Dates
First Submitted
January 16, 2017
First Posted
August 6, 2018
Study Start
June 1, 2015
Primary Completion
April 1, 2018
Study Completion
May 18, 2018
Last Updated
August 6, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share